跳至主要内容
临床试验/ISRCTN23328456
ISRCTN23328456已完成未知

A prospective study for the effects of treatment with adalimumab in patients with psoriasis and psoriatic arthritis

Academic Medical Center (AMC) (Netherlands)0 个研究点目标入组 24 人开始时间: 2007年1月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with psoriatic arthritis and psoriasis
  • 2. Age 18 to 80 years
  • 3. At least two painful and two swollen joints
  • 4. Inadequate respons to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • 5. Effective contraception
  • 6. Signed informed consent

排除标准

  • 1. Use of another Disease Modifying Anti-Rheumatic Drugs (DMARD) than methotrexate within four weeks of baseline
  • 2. Intra-articular injection with corticosteroids within four weeks of baseline
  • 3. Other Tumour Necrotising Factor (TNF)-blocking treatment or treatment with another biological agent within two months of baseline
  • 4. Another skin or connective tissue disease that interferes with the assessment of psoriasis or psoriatic arthritis
  • 5. Active or latent tuberculosis
  • 6. Infection with Human Immunodeficiency Virus (HIV), hepatitis B or hepatitis C virus
  • 7. Severe comorbidity
  • 8. Malignancy other than basal cell carcinoma of skin within ten years of baseline
  • 9. Pregnancy or breastfeeding

研究者

发起方
Academic Medical Center (AMC) (Netherlands)

相似试验